A splicing site mutation in CHMP2B resulting in a C-terminal truncation of the protein was identified in a Danish FTD patient cohort6 and other mis-sense mutations have since been identified in FTD and ALS pedigrees7–12. The gene discussed is CHMP2B; the disease is amyotrophic lateral sclerosis.